Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists

Eur J Med Chem. 2019 Nov 1:181:111564. doi: 10.1016/j.ejmech.2019.111564. Epub 2019 Jul 26.

Abstract

The P2Y14 receptor (P2Y14R) plays a key role in the modulation of inflammatory process, but very few classes of antagonists have been reported. A series of 3-amide benzoic acid derivatives were identified as novel and potent P2Y14R antagonists. The most potent antagonist, 16c, showed comparable activity (IC50 = 1.77 nM) to PPTN, the most potent P2Y14R antagonist reported. Compound 16c demonstrated dramatically improved aqueous solubility and excellent metabolic stability in rat and human microsomes. Investigation of the anti-inflammatory effect of 16c was performed in MSU treated THP-1 cells by flow cytometry, Western Blot and immunofluorescence labeling technology, which exhibited that 16c might be a promising candidate for further research.

Keywords: 3-Amide benzoic acid derivatives; Antagonist; Anti-inflammation; G protein-coupled receptor; P2Y(14) receptor.

MeSH terms

  • Amides / chemical synthesis
  • Amides / chemistry
  • Amides / pharmacology
  • Animals
  • Anti-Inflammatory Agents / chemical synthesis
  • Anti-Inflammatory Agents / chemistry*
  • Anti-Inflammatory Agents / pharmacology*
  • Benzoic Acid / chemical synthesis
  • Benzoic Acid / chemistry*
  • Benzoic Acid / pharmacology*
  • Cell Line
  • Drug Design
  • Humans
  • Molecular Docking Simulation
  • Purinergic P2 Receptor Antagonists / chemical synthesis
  • Purinergic P2 Receptor Antagonists / chemistry*
  • Purinergic P2 Receptor Antagonists / pharmacology*
  • Rats
  • Receptors, Purinergic P2 / metabolism

Substances

  • Amides
  • Anti-Inflammatory Agents
  • P2Y14 receptor, human
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Benzoic Acid